Different characteristics of non culprit plaque by OCT

Original title: Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: A 3-vessel optical coherence tomography study. Reference: Rocco Vergallo et al. Am Heart J 2014;167:59-67.

Recent studies have described different clinical characteristics between ACS patients with and without ruptured culprit plaque. Given the systemic nature of atherosclerosis, the hypothesis of this study is that non culprit lesions would also express different characteristics than culprit lesions.

Based on culprit lesion characteristics, the population was divided in two groups: patients with ruptured plaque at the culprit lesion and patients with non ruptured plaque at the culprit lesion. Prevalence and characteristics of non culprit plaques were compared between these two groups of patients.

118 non culprit lesions were analyzed. Patients in the group with ruptured culprit lesion (n=17) presented non culprit plaque with higher prevalence of fibroatheroma with thin cap (52.9% vs 19.0%; p=0.029) or ruptured (35.3% vs 4.8%; p=0.016) compared to those patients whose culprit lesion was not ruptured (n=21).

In absolute values, the cap of non culprit lesions in the first group measured 107.0 ± 56.5 μm vs 137.3 ± 69.8 μm in the second group, a difference that turned out significative (p=0.035). All lipid content measurement parameters resulted higher in the non culprit plaque patients than in the group of ruptured culprit lesions.

Conclusion

The present study showed different characteristics of non culprit lesions by OCT between those patients presenting ACS caused by ruptured plaques and those whose culprit lesions were not ruptured.

Editorial Comment

This study has the limitation of being retrospective from the Massachusetts General Hospital OCT registry. The use of OCT in the 3 coronary vessels could have been limited by the context of ACS given the its clinically unstable nature and the difficulty to assess distal or ostial lesions. 

SOLACI

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....